"Neurotrek, Inc. - Product Pipeline Analysis, 2013 Update" Is Now Available at Fast Market Research
Neurotrek, Inc. (Neurotrek) is a biotechnology company. The company develops and offers U+, a targeted, non-invasive neuromodulation technology. Its U+ is a proprietary platform which uses ultrasound to modulate brain tissue and nerve tissue in a targeted, non-invasive manner via patterned vibrations. Neurotrek's technology finds application in various areas such as, epilepsy, pain, depression and mood disorder, diagnostic brain mapping, and cognitive abilities and communication. The company develops both consumer-grade and clinical-grade products. Its TDCS and TMS use electrical and...
View full press release